Download book chapters - The University of Arizona Cancer Center

ANNEX A – PUBLICATIONS - Martine P Roudier MD PhD
RESEARCH PATHOLOGIST
1. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant
prostate cancer. Roudier MP1, Winters BR1, Coleman I2, Lam HM1,3, Zhang X1, Coleman
R2, Chéry L1, True LD4, Higano CS5, Montgomery B5, Lange PH1,6, Snyder LA7,Srivastava
S8, Corey E1, Vessella RL1,6, Nelson PS2,5, Üren A9, Morrissey C1. Prostate 2016 Mar 16 online.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate
cancer bone metastases. Haider M, Zhang X, Coleman I, Ericson N, True LD, Lam HM, Brown LG,
Ketchanji M, Nghiem B, Lakely B, Coleman R, Montgomery B, Lange PH, Roudier M, Higano CS,
Bielas JH, Nelson PS, Vessella RL, Morrissey C. Clin Exp Metastasis. 2015 Dec 14.
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the
Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.Zhang X, Coleman IM, Brown
LG, True LD, Kollath L, Lucas JM, Lam HM, Dumpit R, Corey E, Chéry L, Lakely B, Higano CS,
Montgomery B, Roudier M, Lange PH, Nelson PS, Vessella RL, Morrissey C. Clin Cancer Res.
2015 Oct 15;21(20):4698-708.
Experimental hamster infection with a strain of Leptospira borgpetersenii Ballum isolated from a
reservoir mouse in New Caledonia, Matsui M et al, 2015, AJMTH.
Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study. Park JJ,
Roudier MP, Soman D, Mokadam NA, Simkin PA. BMJ Open. 2014 Jul 16;4(7).
A humanized tissue-engineered in vivo model to dissect interactions between human prostate
cancer cells and human bone. Hesami P, Holzapfel BM, Taubenberger A, Roudier MP, Fazli L,
Sieh S, Thibaudeau L, Gregory LS, Hutmacher DW, Clements JA. Clin Exp Metastasis. 2014 Feb
8.
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. Larson
SR, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier MP, Higano CS, True LD, Lange PH,
Montgomery B, Corey E, Nelson PS, Vessella RL, Morrissey C. Prostate. 2013 Jun;73(9):932-40.
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with
metastatic castration-resistant prostate cancer: results from the University of Washington Rapid
Autopsy Series. Morrissey C, Roudier MP, Dowell A, True LD, Ketchanji M, Welty C, Corey E,
Lange PH, Higano CS, Vessella RL. J Bone Miner Res. 2013 Feb;28(2):333-40.
Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage
remodeling during aging or following mechanical injury.
Roudier MP, Li X, Niu QT, Pacheco E, Pretorius JK, Graham K, Yoon BR, Gong J, Warmington K,
Ke HZ, Black RA, Hulme J, Babij P. Arthritis Rheum. 2013 Mar;65(3):721-31.
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. Larson
SR, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier MP, Higano CS, True LD, Lange PH,
Montgomery B, Corey E, Nelson PS, Vessella RL, Morrissey C.Prostate. 2013 Jun;73(9):932-40.
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez , Allison P. Jacob, Jon Jones, Robert Miller, Martine P. Roudier-Meyer,
Ryan Erwert, Jan Pinkas, Dan Branstetter & William C. Dougall. Nature. 2010 Nov
4;468(7320):103-7.
Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine
model of bone metastasis. Canon J, Bryant R, Roudier MP, Osgood T, Jones J, Miller R, Coxon
A, Radinsky R, Dougall WC. Bone. 2010 Mar 6.
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces
bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis.
Holland PM, Miller R, Jones J, Douangpanya H, Piasecki J, Roudier MP, Dougall WC. Cancer Biol
Ther. 2010 Apr 20;9(7).
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier MP, Smith J, Ye Z,
Sohn W, Dansey R, Jun S. Lancet Oncol. 2010 Mar;11(3):275-80. Epub 2010 Feb 10.
The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic
prostate cancer cells.
Morrissey C, Lai JS, Brown LG, Wang YC, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F,
True LD, Corey E, Nelson PS, Vessella RL.
Prostate. 2010 Mar 1;70(4):412-24.
Comparative analyses of chromosome alterations in soft-tissue metastases within and across
patients with castration-resistant prostate cancer.
Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, True LD, Roudier MP, Morrissey
CM, Higano CS, Nelson PS, Vessella RL, Trask BJ. Cancer Res. 2009 Oct 1;69(19):7793-802.
New variants in the Enpp1 and Ptpn6 genes cause low BMD, crystal-related arthropathy, and
vascular calcification.
Babij P, Roudier M, Graves T, Han CY, Chhoa M, Li CM, Juan T, Morony S, Grisanti M, Li X, Yu
L, Dwyer D, Lloyd DJ, Bass MB, Richards WG, Ebeling C, Amato J, Carlson G. J Bone Miner Res.
2009 Sep;24(9):1552-64.
Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of
tumor cells.
Stocking KL, Jones JC, Everds NE, Buetow BS, Roudier MP, Miller RE.
Comp Med. 2009 Feb;59(1):37-45.
In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic
radiotherapy in human tissues.
Thomas R, Chen J, Roudier M, Vessella RL, Lantry LE, Nunn AD.
Clin Exp Metastasis. 2009;26(2):105-19.
Histopathological assessment of prostate cancer bone osteoblastic metastases.
Roudier MP, Morrissey C, True LD, Higano CS, Vessella RL, Ott SM.
J Urol. 2008 Sep;180(3):1154-60.
RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine
model of prostate cancer bone metastasis.
Miller RE, Roudier M, Jones J, Armstrong A, Canon J, Dougall WC.
Mol Cancer Ther. 2008 Jul;7(7):2160-9.
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of
breast cancer bone metastasis.
Canon JR, Roudier M, Bryant R, Morony S, Stolina M, Kostenuik PJ, Dougall WC. Clin Exp
Metastasis. 2008;25(2):119-29.
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph
node metastases.
Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang YC,
Corey E, Lange PH, Higano CS, Vessella RL.
Clin Exp Metastasis. 2008;25(4):377-88.
Targeted expression of csCSF-1 in op/op mice ameliorates tooth defects.
Werner SA, Gluhak-Heinrich J, Woodruff K, Wittrant Y, Cardenas L, Roudier M, MacDougall M.
Arch Oral Biol. 2007 May;52(5):432-43.
Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in
rats.
Roudier MP, Bain SD, Dougall WC. Clin Exp Metastasis. 2006;23(3-4):167-75.
Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and
pepstatin.
Rowe PS, Matsumoto N, Jo OD, Shih RN, Oconnor J, Roudier MP, Bain S, Liu S, Harrison J,
Yanagawa N. Bone. 2006 Oct;39(4):773-86.
26. Roudier M P, Haynes K, Fleman R, Gilbraith K, Bell E, Bain SD, Correlation of Cancer Pain with
Tumor burden in a rat model of prostate bone cancer. Cancer Treatment Reviews, 2005, Vol 31/S1
page S55.
27. Roudier M P, Coleman I M, True L D, Nelson P S, Ott S M, VHigano C S, Vessella R L.
Heterogeneity of Bone Formation and Resorption in Prostate Cancer Bone Metastasis. Cancer
Treatment Reviews, 2005, Vol 31/S1 page S28.
28. Trampont P, Roudier M P, Andrea AM, Nomal N, Mignot TM, Leborgne-Samuel Y, Ravion S,
Clayton J, Mary D, Elion J, Decastel M. The placental-umbilical unit in sickle cell disease
pregnancy: a model for studying in vivo functional adjustments to hypoxia in humans. Hum Pathol.
2004 Nov; 35(11): 1353-9.
29. Roudier MP, Hahn J S, Quinn J E, Ott S M, Vessella R L. Characterization of LuCaP 23.1 and PC3 Prostate cancer intra-tibial metastasis models. Journal of Bone and Mineral Research, 19 (9),
2004.
30. Liu A Y, Roudier MP, True L D. Heterogeneity in primary and metastatic prostate cancer as defined
by cell surface CD profile. American Journal of Pathology.165 (5): 1543-56, 2004.
31. Roudier M P, True L D, Vessella R L, Higano C S. Metastatic conventional prostatic
adenocarcinoma with diffuse chromogranin A and androgen receptor positivity. Journal of Clinical
Pathology. 57(3): 321-323, 2004.
32. Muller P, Roul S, Mahe A, Roudier M, Vaque D, Strobel M. Squamous cell carcinoma on a leg
ulcer in the West Indies. Ann Dermatol Venereol. 131(4):347-50, 2004.
33. Shariat S. F., Roudier M P, Wilcox G E, Kattan M W, Scardino P T, Vessella R. L. Erdamar S,
Nguyen C., Wheeler T M, Slawin K M. Comparison of immunohistochemistry with RT-PCR for the
detection of micrometastastic prostate cancer in lymph nodes. Cancer Research, 63: 4662-4670,
2003.
34. Roudier MP, King S H, Vesselle H, Higano CS, True L H, Ott-Ralph S M, Vessella R L. Evaluation
of concordance between bone histology and Tc99 methylene diophosphonate bone scan in
advanced prostate cancer patients with special reference to pamidronate treatment. Clinical and
Experimental Metastasis, 20: 170-180, 2003.
35. Roudier MP, True L, Higano CS, Ott-Ralph SM, Ellis W, Lange P, Vessella R. Phenotypic
heterogeneity of androgen-independent prostate cancer bone metastases. Human Pathology, 34
(7): 646-653, 2003.
36. Corey E, Brown LG, Quinn JE, Poot M, Roudier MP, Higano CS, Vessella RL: Zoledronic acid
exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer
Res. 9 (1):295-306, 2003.
37. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL.
Establishment and characterization of osseous prostate cancer model: direct intra tibial injection of
human prostate cancer cells. Prostate. 52 (1):20-33, 2002.
38. Roudier MP, Pfitzenmayer J., True L D, Vesselle H J, Higano CS, Vessella R. Evaluation of
Concordance between Bone histology and Tc-99 Methylene Diophosphonate Bone Scan in
Advanced Prostate Cancer Patients with special reference to Pamidronate Treatment. Radiology,
225 suppl: 217, 2002.
39. Influence of the structure of three corals on their resorption kinetics. Fricain JC, Roudier M, Rouais
F, Basse-Cathalinat B, Dupuy B. J Periodontal Res. 1996 Oct;31(7):463-9.
40. The resorption of bone-implanted corals varies with porosity but also with the host reaction.
Roudier M, Bouchon C, Rouvillain JL, Amédée J, Bareille R, Rouais F, Fricain JC, Dupuy B, Kien
P, Jeandot R, et al. J Biomed Mater Res. 1995 Aug;29(8):909-15.
DIAGNOSIS PATHOLOGIST
41. Human T cell leukemia/lymphoma virus type I (HTLV-I) and Pneumocystis carinii associated with
T cell proliferation and haemophagocytic syndrome. Roudier M, Lamaury I, Strobel M. Leukemia.
1997 Mar;11(3):453-4. No abstract available.
42. Cutaneo-mucous manifestations of dengue]. Desruelles F, Lamaury I, Roudier M, Goursaud R,
Mahé A, Castanet J, Strobel M.Ann Dermatol Venereol. 1997;124(3):237-41. French
43. [Pelvic actinomycosis due to an intrauterine device. Two case reports]. Vendittelli F, Mousteau A,
Gallais A, Janky E, Tabaste JL, Roudier M. J Gynecol Obstet Biol Reprod (Paris). 1997;26(3
Suppl):166-8. French. No abstract available.
44. Osteopetrosis and mandibular osteitis in adult. Report of a case in Guadeloupe. Billy-Brissac R,
Foucan L, Roudier M, Trival M. Rev Rhum Engl Ed. 1995 Apr;62(4):303-4. No abstract available.
45. [Conjunctival epidermoid carcinoma and human immunodeficiency virus]. Denis P, Charpentier
D, Roudier M, Lemaire JC, Levin N, Nguyen-Khoa JL. J Fr Ophtalmol. 1994;17(5):366-9. French.
46. [Genital Schistosoma mansoni bilharziasis in women: apropos of 2 cases in Guadeloupe]. BillyBrissac R, Foucan L, Gallais A, Wan-Ajouhu G, Roudier M. Med Trop (Mars). 1994;54(4):345-8. French.
47. [Natural murine infestation by Angiostrongylus costaricensis Morera and Cespedes, 1971 in
Guadeloupe]. Juminer B, Borel G, Mauleon H, Durette-Desset MC, Raccurt CP, Roudier M,
Nicolas M, Perez JM. Bull Soc Pathol Exot. 1993;86(5 Pt 2):502-5. French.
48. [Presence of abdominal angiostrongylosis in Guadeloupe. Apropos of 2 recent cases].
Juminer B, Roudier M, Raccurt CP, Pujol HP, Gerry F, Bonnet R. Bull Soc Pathol Exot.
1992;85(1):39-43. French. Erratum in: Bull Soc Pathol Exot Filiales 1992;85(2):198.
49. [Prolapse of the urethral mucosa in girls]. Gerry F, Pascal Mousselard H, Roudier M. Pediatrie.
1990;45(4):259-62. French.
50. Value of bronchoalveolar lavage in the immunocompromised subject: demonstration of pathogenic
agents and drug pneumopathies]. Boccon-Gibod L, Roudier M. Arch Anat Cytol Pathol.
1986;34(1):22-4. French. No abstract available.
BOOK CHAPTERS
Roudier MP, Corey E, True LD, Higano CS, Ott SM, Vessella RL. Histological, immunophenotypic
and histomorphometric characterization of prostate cancer bone metastases, pp 311 - 339, in The
Biology of Skeletal Metastases, ed. Evan T. Keller and Leland W. Chung. Kluwer Academic
Publishers, Norwell, MA 2004.
EUROPEAN FUNDING
1996 : Installation of a digital pathology and telepathology system in the West Indies
(Guadeloupe, Martinique, French Guyana and Dominica) connected to the French
network of pathology experts for each organ pathology.
MEMBERSHIPS
Intermittent member at ASBMR, AACR, AIP, USCAP, ACR, ADICAP.
Current memberships:
Pathology.
College of American Pathology, Association for Molecular
TEACHING DVDs
1. INFECTIOUS AND DERMATOLOGY : Co-Auteur du CD-ROM de Séminaires de
Pathologie 1996. Communication au Séminaire de Pathologie Infectieuse et
Dermatologique. Productions ADICAP, ICG, Mémoire Directe, Paris, 1996.
2. PEDIATRY : Co-Auteur du CD-ROM de Séminaires de Pathologie 1997 : Auteur d’une
communication au Séminaire de Pathologie Pédiatrique, Productions ADICAP, ICG,
Mémoire Directe, Paris, 1997.
3. TROPICAL and INFECTIOUS DISEASES: Co-Auteur du CD-ROM de Séminaires de
Pathologie 1997 : Auteur d’une communication au Séminaire de Pathologie Infectieuse et
Tropicale, Productions ADICAP, ICG, Mémoire Directe, Paris, 1997.
4. CERVICAL CANCER CYTOLOGY : Auteur du CD-ROM : Le Cancer du Col de l’utérus en
Guadeloupe, Le Frottis, Sa technique, Ses Résultats. CHU de Pointe à Pitre, L Doucet et
M Roudier. Editions TELIDE, Toulouse, 2000 (L).
END OF DOCUMENT